Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial

Auteurs

Florence Lerebours, Sofia Rivera, Marie-Ange Mouret-Reynier, Severine Alran, Laurence Venat-Bouvet, Pierre Kerbrat, Remy Salmon, Veronique Becette, Céline Bourgier, Pascal Cherel, Véronique Boussion, Corinne Balleyguier, Fabienne Thibault, Sandrine Lavau-Denes, Jean-Marc Nabholz, Brigitte Sigal, Martine Trassard, Marie-Christine Mathieu, Anne-Laure Martin, Jerome Lemonnier, Emmanuelle Mouret-Fourme